IVDs (in vitro diagnostics) to be covered in EU vigilance document:
This article was originally published in Clinica
The European Commission's medical device expert group meeting has determined that products covered by the In Vitro Diagnostics Directive should be included in the Commission's vigilance guidance document. Representatives from the Commission, member states and industry decided at their meeting last month that these products should be covered in a new appendix to the document, where the concept of indirect harm would also be addressed.
You may also be interested in...
Ipsen’s business strategy calls for accessing external innovation across its pipeline, combined with geographic expansion, realizing the unmet potential of its marketed products and business efficiencies in manufacturing and operations.
The proposal, which would increase capacity for pandemic supplies, is similar to ideas President Trump embraced pre-pandemic.
Sanofi has named the head of its new API business; Sweden's Enzymatica has hired talent from J&J and L'Oreal; and Bayer has a new transformation officer.